CD19 and type 1 diabetes mellitus: recently reported a special subset of immune cells that characteristically dual expresses key lineage markers of both B and T cells (CD19+CD3+ cells) in type 1 diabetes patients, which proposes stimulating autologous CD4-T cells and may contribute to autoimmunity [40].